Skip to main content

TRIMTECH Therapeutics

Cambridge, United States

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

$31.0M raised
Mar 2025
Seed

Top Investors

Eli LillyCambridge Innovation CapitalDementia Discovery FundPfizer Venture InvestmentsM Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TRIMTECH Therapeutics

How much funding has TRIMTECH Therapeutics raised?
TRIMTECH Therapeutics has raised $31.0M in total funding. The most recent round was Seed. The last funding was announced in March 2025.
Who are TRIMTECH Therapeutics's investors?
TRIMTECH Therapeutics's investors include Eli Lilly, Cambridge Innovation Capital, Dementia Discovery Fund, Pfizer Venture Investments, M Ventures.
Where is TRIMTECH Therapeutics headquartered?
TRIMTECH Therapeutics is headquartered in Cambridge, United States.
What does TRIMTECH Therapeutics do?
TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.
What stage is TRIMTECH Therapeutics at?
TRIMTECH Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"TRIMTECH Therapeutics — Funding & Investors." VCBacked, March 5, 2025, https://www.vcbacked.co/company/trimtech-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2025). TRIMTECH Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/trimtech-therapeutics
Wikipedia (cite web)
{{cite web |title=TRIMTECH Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/trimtech-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .